Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies

Código QR

Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies

Xun Jin,1 Peilan Zhang,1 Li Luo,1 Hao Cheng,1 Yunzu Li,1 Ting Du,1 Bingwen Zou,2 Maling Gou1 1State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, and Collaborative Innovation Center for Biotherapy, Chengdu, People’s Republic of China; 2Department...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Jin X, Zhang P, Luo L, Cheng H, Li Y, Du T, Zou B, Gou M
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2016
Materias:	Bladder cancer Drug delivery Nanoparticles Intravesical therapy Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/df586edb1eca459b85ac37591112e400
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Magnetic multiwalled carbon nanotubes with controlled release of epirubicin: an intravesical instillation system for bladder cancer
por: Suo N, et al.
Publicado: (2019)

Functional Nanomedicines for Targeted Therapy of Bladder Cancer
por: Chao Tang, et al.
Publicado: (2021)

Intravesical gemcitabine for non-muscle invasive bladder cancer: An abridged Cochrane Review
por: Mi Ah Han, et al.
Publicado: (2021)

Nucleotide Oligomerization Domain-like receptor 4 (NLR4) Gene Expression and Interleukin 1-β (IL 1-β) Level in Urine Samples Before and After Intravesical BCG Therapy For Treatment of Bladder Cancer
por: Ahmed Samar Abd Elmoaty Eissa, et al.
Publicado: (2021)

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain
por: Ana Plata, et al.
Publicado: (2021)

Drug delivery system based on dendritic nanoparticles for enhancement of intravesical instillation
por: Qiu X, et al.
Publicado: (2017)

The Impact of SARS-CoV-2 Pandemic on Time to Primary, Secondary Resection and Adjuvant Intravesical Therapy in Patients with High-Risk Non-Muscle Invasive Bladder Cancer: A Retrospective Multi-Institutional Cohort Analysis
por: Matteo Ferro, et al.
Publicado: (2021)

Dispositivo intrauterino intravesical en expulsión en embarazo de tercer trimestre: reporte de un caso
por: Perucca P,Ernesto, et al.
Publicado: (2011)

Risk factors and prognosis of intravesical recurrence after surgical management of upper tract urothelial carcinoma: A 30-year single centre experience
por: Mohamed Mohamed Elawdy, et al.
Publicado: (2017)

Role of Survivin in Bladder Cancer: Issues to Be Overcome When Designing an Efficient Dual Nano-Therapy
por: Maria Arista-Romero, et al.
Publicado: (2021)

Hydrophilic mesoporous carbon nanospheres with high drug-loading efficiency for doxorubicin delivery and cancer therapy
por: Wang H, et al.
Publicado: (2016)

Doxorubicin/Cisplatin-Loaded Superparamagnetic Nanoparticles As A Stimuli-Responsive Co-Delivery System For Chemo-Photothermal Therapy
por: Khafaji M, et al.
Publicado: (2019)

Development And In Vitro Characterization Of Bladder Tumor Cell Targeted Lipid-Coated Polyplex For Dual Delivery Of Plasmids And Small Molecules
por: Samaddar S, et al.
Publicado: (2019)

Codelivery of thioridazine and doxorubicin using nanoparticles for effective breast cancer therapy
por: Jin X, et al.
Publicado: (2016)

Preparation and Evaluation of Doxorubicin-Loaded PLA–PEG–FA Copolymer Containing Superparamagnetic Iron Oxide Nanoparticles (SPIONs) for Cancer Treatment: Combination Therapy with Hyperthermia and Chemotherapy
por: Khaledian M, et al.
Publicado: (2020)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Zheng Liu, et al.
Publicado: (2021)

DPPG2-Based Thermosensitive Liposomes with Encapsulated Doxorubicin Combined with Hyperthermia Lead to Higher Doxorubicin Concentrations in the Bladder Compared to Conventional Application in Pigs: A Rationale for the Treatment of Muscle-Invasive Bladder Cancer
por: van Valenberg FJP, et al.
Publicado: (2021)

One-Step Microfluidic Fabrication of Multi-Responsive Liposomes for Targeted Delivery of Doxorubicin Synergism with Photothermal Effect
por: Lv S, et al.
Publicado: (2021)

Application of nanotechnology in the diagnosis and treatment of bladder cancer
por: Yadong Xu, et al.
Publicado: (2021)

CD20 monoclonal antibody targeted nanoscale drug delivery system for doxorubicin chemotherapy: an in vitro study of cell lysis of CD20-positive Raji cells
por: Jiang S, et al.
Publicado: (2016)

Lipid-polymer hybrid nanoparticles for controlled delivery of hydrophilic and lipophilic doxorubicin for breast cancer therapy
por: Tahir N, et al.
Publicado: (2019)

Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
por: Xia Y, et al.
Publicado: (2017)

AlPcS4-PDT for gastric cancer therapy using gold nanorod, cationic liposome, and Pluronic® F127 nanomicellar drug carriers
por: Xin J, et al.
Publicado: (2018)

Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma
por: Masato Yanagi, et al.
Publicado: (2021)

Ligand-based targeted therapy: a novel strategy for hepatocellular carcinoma
por: Li M, et al.
Publicado: (2016)

A New Ferroptosis-Related lncRNA Signature Predicts the Prognosis of Bladder Cancer Patients
por: Mei Chen, et al.
Publicado: (2021)

Enhanced photo/chemo combination efficiency against bladder tumor by encapsulation of DOX and ZnPC into in situ-formed thermosensitive polymer hydrogel
por: Huang Z, et al.
Publicado: (2018)

Dual tumor-targeted poly(lactic-co-glycolic acid)–polyethylene glycol–folic acid nanoparticles: a novel biodegradable nanocarrier for secure and efficient antitumor drug delivery
por: Chen J, et al.
Publicado: (2017)

Editorial: Stimuli-Responsive Nanoparticles for Anti-cancer Therapy
por: Saji Uthaman, et al.
Publicado: (2021)

Intravesical Chemohyperthermia vs. Bacillus Calmette-Guerin Instillation for Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis
por: Hongda Zhao, et al.
Publicado: (2021)

A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth
por: Zhang D, et al.
Publicado: (2018)

Polymer-Coated Nanoparticles for Therapeutic and Diagnostic Non-<sup>10</sup>B Enriched Polymer-Coated Boron Carbon Oxynitride (BCNO) Nanoparticles as Potent BNCT Drug
por: Chen-Wei Chiang, et al.
Publicado: (2021)

MANEJO LAPAROSCÓPICO DE DISPOSITIVO INTRAUTERINO INCRUSTADO EN PARED VESICAL CON LITIASIS VESICAL SECUNDARIA
por: Zarhi T,Jaime, et al.
Publicado: (2009)

Nanocarriers for Inner Ear Disease Therapy
por: Xiaoxiang Xu, et al.
Publicado: (2021)

Highly effective photothermal chemotherapy with pH-responsive polymer-coated drug-loaded melanin-like nanoparticles
por: Zhang C, et al.
Publicado: (2017)

Smart Design of Mitochondria-Targeted and ROS-Responsive CPI-613 Delivery Nanoplatform for Bioenergetic Pancreatic Cancer Therapy
por: Yi-Mei Zhang, et al.
Publicado: (2021)

Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
por: Yu-Ching Wen, et al.
Publicado: (2021)

AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy
por: Flak DK, et al.
Publicado: (2020)

Targeted delivery of doxorubicin to HER2 positive tumor models
por: Gomari H, et al.
Publicado: (2019)

Functionalized Nanoparticles in Prevention and Targeted Therapy of Viral Diseases With Neurotropism Properties, Special Insight on COVID-19
por: Meishen Ren, et al.
Publicado: (2021)